Charles Kummeth
2017
In 2017, Charles Kummeth earned a total compensation of $9.1M as President and CEO at Bio-Techne.
Compensation breakdown
| Non-Equity Incentive Plan | $1,053,594 |
|---|---|
| Option Awards | $3,549,359 |
| Salary | $880,000 |
| Stock Awards | $3,550,140 |
| Other | $43,798 |
| Total | $9,076,890 |
Kummeth received $3.6M in stock awards, accounting for 39% of the total pay in 2017.
Kummeth also received $1.1M in non-equity incentive plan, $3.5M in option awards, $880K in salary and $43.8K in other compensation.
Rankings
In 2017, Charles Kummeth's compensation ranked 746th out of 14,666 executives tracked by ExecPay. In other words, Kummeth earned more than 94.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 746 out of 14,666 | 95th |
Division Manufacturing | 242 out of 5,772 | 96th |
Major group Chemicals And Allied Products | 60 out of 2,075 | 97th |
Industry group Drugs | 41 out of 1,731 | 98th |
Industry Biological Products, Except Diagnostic Substances | 6 out of 313 | 98th |
Source: SEC filing on September 9, 2019.
Kummeth's colleagues
We found three more compensation records of executives who worked with Charles Kummeth at Bio-Techne in 2017.